Il 17 News Today

>> everything we have to do with. look, if we finally beat medicare. >> thank you. president biden, biden crashesee and burns. is it time for the old: switch guru? >> i really dont know what he a said at the end of this and i dont think he knowsd ofsentenc said, that at the end of the day, joe biden looks likeof the caricature that conservative media has been painting. and there were no clips tonigh t . >> right. this was you saw it before your eyes. the media cover upyour eyes.is f is...

Expert dermatologist Dr Linda Stein Gold discusses the pathophysiology of psoriasis as target for treatment.

Skin is our first line of defense, protecting us from damage and keeping out unwanted visitors. As we age, it weakens. Research may have found a workaround.

Analysis of 1,025 recently switched PsA patients reveals second- or later-line usage of IL-17, IL-23, and JAK inhibitors growing in popularity....

This new data should be taken into account before biologics prescriptions are made for patients with conditions such as psoriasis.

Despite the increased efficacy of BMS’ Sotyktu over Amgen’s Otezla, dermatologists continue to express a desire for additional oral agents that bring...

Mexico: A recent study published in Scientific Reports has assessed the plasma metabolome of long COVID patients two years after infection.The study led by researchers at the Autonomous University of...

Dermatology experts review available treatment options for the treatment of rare dermatological disorders.

An approved medication for the treatment of psoriasis is now starting a significant clinical investigation. Patients who have just received a type 1 diabetes diagnosis will test the medication. According to the theory, the medication might maintain the patient's remaining capacity to produce insulin.

Gloria Choi, a neuroscientist in MIT’s Department of Brain and Cognitive Sciences, studies how the immune system influences neurological development and social behavior.